期刊文献+

合成肽检测巨细胞病毒酶联免疫方法的建立及应用 被引量:4

Establishment of ELISA Method of Detecting Human Cytomegalovirus Using Synthetic Peptide and its Application
原文传递
导出
摘要 目的 应用合成肽建立检测人巨细胞病毒 (HCMV)特异敏感的酶联免疫方法 ,并用于临床检测患者血清中HCMV -IgM。方法 根据人巨细胞病毒PP15 0氨基酸序列 ,利用计算机辅助设计 ,决定含HCMVPP15 0较强抗原决定簇的单链多肽序列 ,合成肽作抗原 ,建立检测抗HCMV -IgM的酶联免疫吸附试验 (ELISA)法 ,并用聚合酶链反应 (PCR)方法检测全血中HCMVDNA ,比较ELISA与PCR两种方法的相关性。结果 本实验所建立的检测抗HCMV -IgM的ELISA方法具有较好的特异性 ,正常孕妇血清中抗HCMV -IgM阳性率与HCMVDNA存在相关性。结论 本研究所建立的以合成多肽作抗原检测巨细胞病毒酶联免疫方法具有较好的特异性 ,简单、快速 ,适用与临床标本的检测。 Objective To establish the ELISA method by using synthetic peptide for detection of IgM antibodies to human cytomegalovirus(HCMV).Methods According to HCMV PP150 sequence of amino acid and nucleotide,the peptide sequence was decided by computer with some program of software of protein.The ELISA method using synthetic peptide as antigen was developed and was applied to detected anti-HCMV IgM in sera of normal pregnant woman and habitual abortion woman.The HCMV DNA were detected by polymerase chain reaction(PCR).Results The positive rates of anti-HCMV IgM in different populations were as follows:9 17%(11/120) in normal pregnant woman,37 5%(24/64) in habitual abortion woman.The ELISA method have good speciality.The positive rate of HCMV DNA was significantly related to that of anti-HCMV IgM(P<0 005).Conclusions This ELISA method using synthetic peptide as antigen was special,sensitive,simple and quick,it can be applied to detect HCMV IgM in sera of patients with active infection of HCMV.
出处 《中国医师杂志》 CAS 2002年第8期852-854,共3页 Journal of Chinese Physician
关键词 人巨细胞病毒 酶免疫吸附试验 合成肽 HCMV Human,cytomegalovirus ELISA Synthetic,peptide
  • 相关文献

参考文献9

  • 1Cope AV,Swenyp P,Sabin C,et al.Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation[J] .J Med Virol,1997,52:200~205
  • 2Limaye AP,Bowden RA,Myerson D,et al.Cytomegalovirus disease occurring before engraftment in marrow transplant recipient[J].Clin Infect Dis,1997,2 4:830~835
  • 3Gerna G,Revello MG,Percivalle E,et al.Quantity of human cytomegaloviru s by using monoclonal antibodies to different viral proteins[J].J Clin Microb ilol,1990,28:2681~2688
  • 4Emery VC,Cope AV,Bowen EF.The dynamics of human cytomegalovirus replic ation in vivo[J].J Exp Med,1999,190:177~182
  • 5Sara BM,Joan KK,Alexander JR,et al.Cervical shedding of cytomegaloviru s in human immunodeficiency virus Typel-infected women[J].J Med virol,1999, 59:469~473
  • 6Stagno S.In:Remington JS,Klein JO editor.Infectous diseases of the fet us and newborn infant[J].Philadelphia:WB saunder CO.,1995,312~353
  • 7Ljungdahl-stahle E,Schloss L,Sundqvist VA,et al.Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus t o antiviral drugs in vitro[J].Antiviral Res,1998,40:105~112
  • 8Numazaki K,Chiba S.Current aspects of diagnosis and treatment of cytom egalovirus infections in infants[J].Clin Diagn Virol,1997,8:169~181
  • 9Britt WJ,Vugler CG.Antiviral antibody responses in mother and newborn infants with clinical and subclinical congenital cytomegalovirus infections[J] .J infect Dis,1990,161:214~218

同被引文献31

  • 1Distefano AL, Alonso A, Martin F,et al. Human cytomegalovirus: detection of congenital and perinatal infection in Argentina [ J ]. BMC Pediatr, 2004,23 ( 1 ) : 11.
  • 2Revello MG, Gerna G. Diagnosis and management of Human cytomegalovirus infection in the mother, fetus, and newborn infant. [ J]. Clin Microbiol Rev,2002,15 (4) :680-715.
  • 3Revello MG, Percivalle E, Gerna G. Immunoglobulin M to the membrane of uninfected fibroblasts in primary Human cytomegalovirus infections [ J ]. Mierobiologica, 1986,9(2) :127-138.
  • 4Severi B, Landini MP, Govoni E. Human cytomegalovirus morphogenesis : an ultrastructural study of the late cytoplasmic phases [ J ]. Arch Virol, 1988,98 ( 1-2 ) : 51-64.
  • 5Greijer AE, Van De Crommert JM, Stevens SJ, et al. Molecular fine-specificity analysis of antibody respon- ses to Human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays [ J ]. J Clin Microbiol, 1999,37 ( 1 ) : 179-188.
  • 6Takahashi I, Sugiura S, Ohta H, et al. Epitope analysis of antibodies in Japanese to Human cytomegalovirus phosphoprotein 150 with synthetic peptides [ J ] Biosci Biotechnol Biochem, 2002,66 ( 11 ) : 2402-2405.
  • 7Genser B, Truschnig-Wilders M, Stunzner D, et al. Evaluation of five commercial enzyme immunoassays for the detection of Human cytomegalovirus-specific IgM antibodies in the absence of a commercially avail- able gold standard[ J]. Clin Chem Lab Med,2001,39 ( 1 ) :62-70.
  • 8Sun A, Chang JG, Kao CLet al. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behcet's disease[Jl. J Oral Pathol Med, 1996,25 (5) :212-218.
  • 9Kaija I, Anu S, Leena K,et al. Cytomegalovirus increases collagen synthesis in chronic rejection in the louse[J]. Nephrol Dial Transplant,2002,17: 772-779
  • 10Tsalamandris C, Young KW. The tricontinental Mycophenylate Mofetil renal transplantation study group[J]. Transplantation,1996,61:1029-1037

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部